Global X Genomics & Biotechnology ETF
Price through Oct 5 · Flows through Aug 23. Figures use the latest available records, not a live quote. Fund details retrieved Oct 5. Holdings snapshot retrieved Oct 5.
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1Y SHOWN
Recent fund-flow records are unavailable, while the price has returned +59.1% so far this year. At 0.50% a year it is not the cheapest way in — FDHT has a reported fee of 0.39%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 9.42% | $203.21 | +6.9% | ||
| 2 | TWSTTWIST BIOSCIENCE | 7.98% | $205.00 | +8.7% | ||
| 3 | TXG10X GENOMICS | 7.61% | $97.74 | +4.5% | ||
| 4 | ILMNILLUMINA | 5.77% | $293.69 | +7.6% | ||
| 5 | GHGUARDANT HEALTH | 5.47% | $187.22 | +5.3% | ||
| 6 | NTRANATERA | 5.44% | $425.64 | +3.7% | ||
| 7 | TECHBIO-TECHNE | 3.41% | $72.58 | +0.2% | ||
| 8 | VRTXVERTEX PHARMACEUTICALS | 3.18% | $503.50 | -0.2% | ||
| 9 | QGENQIAGEN NV | 3.08% | $45.79 | +2.3% | ||
| 10 | BMRNBIOMARIN PHARMACEUTICAL | 2.91% | $57.54 | +0.6% | ||
| 11 | CRSPCRISPR THERAPEUTICS AG | 2.71% | $57.34 | +3.4% | ||
| 12 | VCYTVERACYTE | 2.57% | $47.67 | +4.1% | ||
| 13 | CAICaris Life Sciences | 2.45% | $30.39 | +7.4% | ||
| 14 | BNTXBIONTECH SE | 2.46% | $97.64 | +0.8% | ||
| 15 | ARWRARROWHEAD PHARMACEUTICALS | 2.39% | $62.35 | -2.9% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 41| 1 week | +2.8% |
| 1 month | +12.5% |
| 3 months | +23.8% |
| 6 months | +63.6% |
| YTD | +59.1% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 9.4% of the book; the top ten carry 56%. Spread across 51+ names, it behaves like roughly 23 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $49M | $46M |
| LLY ELI LILLY | $32M | $30M |
| TWST TWIST BIOSCIENCE | $4M | $2M |
| DHR DANAHER | $4M | $1M |
| NTRA NATERA | $2M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat GNOM on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $888.3B | +$19B | -47bp on fee · 10492× the assets · +$19B in over the month | Head-to-head |
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -47bp on fee · 490× the assets · +$286M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.4B | +$187M | -48bp on fee · 111× the assets · +$187M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -47bp on fee · 215× the assets · +$199M in over the month | Head-to-head |
| SPYG State Street SPDR Portfolio S&P 500 Growth ETF | 0.04% | $56.2B | +$717M | -46bp on fee · 663× the assets · +$717M in over the month | Head-to-head |